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The high level of genetic variability of Human Immunodeficiency Virus type 1 (HIV-1) is caused by the low fidelity of its replication machinery. 
This leads to evolution of swarm-like viral populations often described as quasispecies. High-throughput sequencing (HTS) technology 
provides higher resolution over Sanger sequencing, enabling detection of low frequency variant genomes. However, quasispecies analysis is 
still a challenge due to the systematic noise, introduced by HTS technology. This leads to the increase in type I errors (also known as false 
positives) and the underlying genetic diversity, which can lead to mathematically insolvable type II errors (also known as false negatives). We 
have developed a pipeline using the tools in the High-performance Integrated Virtual Environment (HIVE), an HTS platform designed for big 
data analysis and management, to analyze viral populations within each sample and identify their subtype classification and recombination 
patterns of recombinants. RNA was extracted from 70 plasma samples of chronic HIV-1 infected patients. The 3’ half genomes of HIV-1 were 
amplified using RT-PCR and PCR products were sequenced using Illumina MiSeq. The paired end reads for each sample were assembled
using Geneious software and analyzed for presence of HIV-1 quasispecies using HIVE tools. Subtype analysis of 70 samples using 
Geneious software identified 17 A1s, 4 Bs, 30 Cs, 1 D, 6 CRF02_AG, and 12 unique recombinant forms (URFs). Additionally, we found up to 
178 ambiguous bases in the consensus sequences from 41 viral samples (58.6%), suggesting the presence of viral subpopulations. 
However, Geneious could not determine the major quasispecies populations in each sample. We analyzed the same HTS reads using the 
HIV-1 quasispecies analysis pipeline and found one predominant population in 11 samples (15.7 %), two to ten distinct populations in 45 
samples (64.3%), 11-20 in 13 samples (18.16%), and 26 in one sample (1.4 %). Interestingly, two equally major viral populations that were 
not detected by Geneious were identified in five samples (7.1%) by HIVE. The HIV-1 quasispecies analysis pipeline is reliable and more 
sensitive in its ability to identify distinct viral populations and the recombination patterns not identified by the Geneious software.
High-throughput sequencing (HTS) technology has the ability to characterize HIV-1 genome sequences with higher resolution over Sanger 
sequencing. However, quasispecies analysis of half or whole genome sequence is still a challenge due to the systematic noise introduced by 
the HTS technology. We have developed a pipeline to identify the distinct viral populations, subtypes and recombination breakpoints in each 
sample using the High-performance Integrated Virtual Environment (HIVE).
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ABSTRACT
Figure 2. Sankey plots generated in HIVE using hexahedron tool depicting subtype, quasispecies and 
recombination pattern. Sankey plot (A) depicts sample PK040 having two predominant populations of subtype 
A1, (B) two subtypes, A1 and C observed in sample 707010038, (C) recombination between A1 and CRF02 seen 
in sample PK006 and (D) single predominant A1 population in sample PK016. Width of the sankey plot is a 
reference to the coverage by reads in the area. For each sample different colors represent different subtypes. 
HIV-1 ANALYISIS PIPELINE
Figure 1. The workflow for the identification of quasispecies, subtypes and recombination breakpoints in HIV-1 infected patient 
samples  in HIVE
METHOD
RNA was extracted from 70 plasma samples of chronic HIV-1 infected patients. The 3’ half genomes of HIV-1 were amplified using RT-PCR and 
PCR products were sequenced using Illumina MiSeq. The paired end reads for each sample were assembled using Geneious software and 
analyzed for presence of HIV-1 quasispecies using HIVE tools. The quality control analysis of the raw reads was done in HIVE and then the 
reads were mapped to the 20 reference set using HIVE-hexagon. The nearest neighbors were selected from the alignment results and then raw 
reads were mapped to the nearest neighbors. Clonal discovery tool, Hexahedron was run on the alignment using mutual frame of the nearest 
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Table 1. Analysis of genetic populations in 70 chronic infection samples
Samples highlighted in red ink contain more than one predominant population.
CONCLUSIONS 
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Figure 3. Identification of two major and five minor quasispecies populations, recombination patterns 
and genetic distances between the clones. Two predominant clones: clone 1 and 2 were verified as 
representative of subtype A1 and C using REGA subtyping tool. Phylogenetic trees were constructed for each 
minor clone with the overlapping clones in the region using MEGA software (D-H) to estimate the genetic 
distances between major and minor clones.
The HIV-1 quasispecies analysis pipeline is reliable and more sensitive in 
its ability to identify distinct major and minor viral quasispecies populations 
not identified by Geneious software and determine the recombination 
patterns between different subtypes within the viral quasispecies 
populations in each sample.
SUMMARY 
• In chronic HIV-1 infection samples multiple viral populations (1-26) were 
detected.
• Out of 70 samples, five (7.1%) samples were identified with two 
predominant viral populations by HIVE, not identified by Geneious.
• On comparing the subtyping and recombination analysis results of the 
predominant populations obtained from HIVE with the consensus 
sequences obtained by Geneious, the results were found comparable.
AIM
The aim of this study is to design a workflow which is reliable and more sensitive  in identifying the major and minor viral quasispecies in the 
HIV-1 infected samples using the HTS data.
Figure 4. Occurrence of quasispecies populations in 70 samples.
Percent samples with minor clonal populations are shown.















703010957 95,554 C 1 1 0 705010661 31,081 C 1 6 0
704010566 26,700 C 1 1 0 705010801 4,704 C 1 6 0
707010225 2,417 D 1 1 1 706010375 119,000 C 1 6 1
PK005 610 CRF02 1 1 2 PK007 106,000 A1 1 6 2
PK009 173,000 C 1 1 0 PK038 456,000 CRF02 1 6 5
PK011 8,750 URF 1 1 2 700010501 31,875 B 1 7 0
PK016 13,000 A1 1 1 0 704010715 319,000 C 1 7 0
PK026 5,350 A1 1 1 26 PK015 300,000 URF 1 7 6
PK032 6,400 CRF02 1 1 44 707010038 17,213 A1 and C 2 7 30
PK034 4,665 A1 1 1 28 702010322 57,901 C 1 8 4
PK036 96,500 A1 1 1 20 706010413 78,000 C 1 8 0
706010391 271,000 C 1 2 0 PK023 65,500 URF 1 8 28
PK021 93,500 A1 1 2 42 PK003 13,600 URF 2 8 101
PK025 26,900 URF 1 2 17 702010350 85,381 C 1 9 0
703010234 183,452 C 1 3 0 704010486 253,000 C 1 9 1
703010619 29,059 C 1 3 0 PK017 119,000 A1 1 9 178
703010835 32,974 C 1 3 3 PK027 111,500 A1 1 9 46
703011871 150,182 C 1 3 0 703010632 43,600 C 1 10 0
705010614 98,700 C 1 3 0 705010699 46,057 C 1 10 4
707010277 97,122 URF 1 3 0 PK008 625,000 URF 1 10 129
PK004 464,000 A1 1 3 4 PK033 425,500 URF 1 10 34
PK040 111,000 A1 2 3 43 700010329 11,014 B 1 11 0
702010675 146,346 C 1 4 5 707010134 15,208 URF 2 11 0
703010523 88,878 C 1 4 0 PK018 88,500 A1 1 11 79
705010474 40,497 C 1 4 0 707010585 79,367 URF 2 14 60
707010169 28,598 A1 1 4 0 PK006 710,000 URF 1 14 9
707010789 22,880 A1 1 4 5 PK019 760,000 CRF02 1 15 134
PK039 60,000 CRF02 1 4 11 PK002 488,000 A1 1 16 4
700010516 10,310 B 1 5 0 700010260 74,588 B 1 18 0
705010366 15,329 C 1 5 0 PK013 193,000 A1 1 18 24
PK031 225,500 A1 1 5 0 705010645 425,760 C 1 19 1
PK035 461,500 CRF02 1 5 3 PK020 208,000 A1 1 19 131
702010118 32,081 C 1 6 2 702010133 591,344 C 1 20 2
705010303 26,833 C 1 6 0 703010539 97,857 C 1 20 0
705010381 21,352 C 1 6 0 PK010 1,250 C 1 26 NA
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